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Background: The interactions of oxidized low-density lipoprotein (LDL) and macrophages are hallmarks in the
development of atherosclerosis. The biological activities of the modified particle in these cells are due to the
content of lipid oxidation products and apolipoprotein modification by oxidized phospholipids.
Results: It was the aim of this study to determine the role of short-chain oxidized phospholipids as components of
modified LDL in cultured macrophages. For this purpose we investigated the effects of the following oxidized
phospholipids on cell viability and apoptosis: 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine (PGPC),
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC) and oxidized alkylacyl phospholipids including
1-O-hexadecyl-2-glutaroyl-sn-glycero-3-phosphocholine (E-PGPC) and 1-O-hexadecyl-2-(5-oxovaleroyl)-sn-glycero-3-
phosphocholine (E-POVPC). We found that these compounds induced apoptosis in RAW264.7 and bone marrow-
derived macrophages. The sn-2 carboxyacyl lipid PGPC was more toxic than POVPC which carries a reactive
aldehyde function in position sn-2 of glycerol. The alkylacyl phospholipids (E-PGPC and E-POVPC) and the respective
diacyl analogs show similar activities. Apoptosis induced by POVPC and its alkylether derivative could be causally
linked to the fast activation of an acid sphingomyelinase, generating the apoptotic second messenger ceramide. In
contrast, PGPC and its ether analog only negligibly affected this enzyme pointing to an entirely different
mechanism of lipid toxicity. The higher toxicity of PGPC is underscored by more efficient membrane blebbing from
apoptotic cells. In addition, the protein pattern of PGPC-induced microparticles is different from the vesicles
generated by POPVC.
Conclusions: In summary, our data reveal that oxidized phospholipids induce apoptosis in cultured macrophages.
The mechanism of lipid toxicity, however, largely depends on the structural features of the oxidized sn-2 chain.
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Macrophages are prominent cells in atherosclerotic
lesions. Within the fraction of lesional macrophages in a
proliferating state, a subset becomes apoptotic or necrotic
[1]. Studies of advanced atherosclerotic lesions revealed a
strong correlation between macrophage cell death and the
incidence of plaque rupture associated with acute vascular
events [2]. A very early and presumably initiating event in
atherogenesis is the focal retention of modified low-
density lipoprotein (e.g. oxidized (ox)LDL) in the suben-
dothelial space. Some of the particles that accumulate* Correspondence: albin.hermetter@tugraz.at
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to be oxidized either prior to uptake into the arterial wall
or subsequently due to intracellular chemical processes,
e.g. free radical-mediated modifications. The modified
lipoprotein particles can inhibit or induce cell death, de-
pending on the extent of lipoprotein oxidation and lipo-
protein dose [3]. In cell culture, apoptosis of macrophages
can be initiated by minimally (e.g. by Fe2+) modified LDL
(mmLDL), in which the lipids but not the apolipoproteins
are oxidized [4]. From this observation it can be inferred
that the oxidized lipids are largely responsible for the toxic
effects of this particle. It has been shown that the toxicity
of oxidized phospholipids (oxPL) is increased in cells
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ity within minutes leading to the formation of the second
messenger ceramide, which mediates the apoptotic signal
in vascular cells including macrophages, endothelial cells
and vascular smooth muscle cells [3,6-8]. Ceramide acti-
vates several apoptotic signaling pathways. In vascular
smooth muscle cells, the stress-induced protein kinases
JNK and p38 MAPK have been identified as such compo-
nents of cells exposed to mmLDL [7].
It has already been shown that ceramide-mediated
apoptosis can also be induced in these cells by oxPL [7].
These compounds are generated from polyunsaturated
phosphatidylcholines in LDL under the conditions of
oxidative stress. Among a plethora of lipid oxidation
products, oxPL, such as 1-palmitoyl-2-(5-oxovaleroyl)-
sn-glycero-3-phosphocholine (POVPC) and 1-palmitoyl-
2-glutaroyl-sn-glycero-3-phosphocholine (PGPC), are
present in mmLDL [9]. They show a high capacity to in-
duce apoptosis in vascular smooth cells [10] and macro-
phages, especially if the latter cells sense ER stress [5].
Both compounds are oxidation products of phosphati-
dylcholines containing arachidonic acid in the sn-2 pos-
ition of glycerol. They are characterized by a short fatty
acyl chain in position sn-2 and a hydrophobic, long-
chain, fatty acid in the sn-1 position of glycerol. In
addition to diacyl-phospholipids, LDL contains the 1-O-
alk(en)yl-2-acyl-analogs which are also modified by
radical-mediated oxidation [11]. The truncated diacyl
and alk(en)ylacyl phospholipids share similar structural
features with two highly bioactive lipoprotein and mem-
brane components, namely platelet-activating factor
(PAF) and lysolecithin [12,13]. They are more polar than
unmodified membrane or lipoprotein phospholipids.
Since they contain only one long hydrophobic sn-1 acyl
or alkyl chain, they exchange easily between tissues,
cells, and lipoproteins [14,15].
Exposure of vascular smooth muscle cells to POVPC
and to a lesser extent PGPC elicited fast activation of an
aSMase in these cells [7,10] pointing to an effect on the
protein level. Although both oxPL lead to the same end-
point (apoptosis), their mechanisms of toxicity are likely
different. The sn-2-aldehydoacyl phospholipid POVPC
chemically interacts with the free amino groups of pro-
teins or phospholipids via Schiff base formation [16].
After cellular uptake, most of the lipid is retained in the
cell surface. In contrast, PGPC containing a carboxyacyl
residue in position sn-2 can only physically interact with
the molecules in its close vicinity and is rapidly interna-
lized by the cells [14,15].
It was the aim of this study to find out whether and to
what extent the apoptotic effects of mmLDL are mediated
by truncated diacylphospholipids and the corresponding
alkylacyl phospholipids in cultured macrophages. For this
purpose, we used chemically defined PGPC and POVPC aswell as their 1-O-hexadecyl analogs and determined their
toxicity in the murine macrophage-like cell line RAW264.7
and bone marrow-derived mouse macrophages (BMM). Al-
though the latter cells proved to be more sensitive towards
the oxPL, both cell types showed the same tendencies. The
four lipids under investigation mainly induced apoptosis in
these cells. PGPC was more toxic than POVPC. The alkyla-
cyl phospholipids and the respective diacyl analogs show
very similar activities. Apoptosis induced by POVPC and its
alkylether derivative could be causally linked to the activity
of aSMase. The more toxic lipids PGPC and its ether ana-
log hardly showed any effect on this enzyme pointing to an
entirely different mechanism of lipid toxicity. The higher
toxicity of PGPC is underscored by more efficient mem-
brane blebbing from the apoptotic cells producing lots of
lipid particles that in turn contain high amounts of oxPL




Oxidized phospholipids (PGPC and POVPC) were synthe-
sized in our laboratory as previously described [17].
1-O-alkyl-ether analogs were prepared starting from 1-O-
hexadecyl-sn-glycero-3-phosphocholine and glutaric acid
anhydride as described for the acylation of the 1-acyl-
phospholipid [17]. 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine (POPC) was synthesized according to the
procedure of Hermetter A., Stutz H., Franzmaier R., Paltauf
F. (1989) [18]. 1-palmitoyl-sn-glycero-3-phosphocho-
line (PLPC) was purchased from Bachem (Bubendorf,
Switzerland). Chemicals for gel electrophoresis were from
BioRad Laboratories (Hercules, CA), unless otherwise noted.
NB19 was kindly provided by Dr. Hans-Peter Deigner
(Frauenhofer EXIM/CEOS, Rostock, Germany). Organic
solvents and all other chemicals were purchased from Carl
Roth (Karlsruhe, Germany), Sigma-Aldrich (Steinheim,
Germany) or Merck (Darmstadt, Germany). Tissue cul-
ture materials were obtained from Sarstedt (Nürnbrecht,
Germany) or Greiner (Kremsmünster, Austria). Dulbecco’s
modified Eagle medium (DMEM, 4,5 g/l Glucose) with
and without phenol red and heat-inactivated fetal bovine
serum, VybrantW MTT Cell proliferation Assay kit
(V-13154), VybrantW apoptosis assay kit#2 (V-13241), F4/
80 antibody and matching isotype control and staurospor-
ine were from Invitrogen (Leek, Netherlands). PBS and cell
culture supplements were obtained from PAA (Linz,
Austria) unless otherwise indicated. “Fluids” for flow
cytometry, FACS tubes, solutions and cells strainers
were from BD Biosciences (Heidelberg, Germany).
Cell culture
The macrophage-like cell line RAW264.7 (ATCC No. TIB-
71, American Type Culture collection, Rockville, MD,
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25 mM HEPES, 4 mM L-glutamine, without sodium pyru-
vate) supplemented with 10% heat-inactivated fetal calf
serum (FCS) and 100 U/ml penicillin/streptomycin at 37°C
in humidified CO2 (5%) atmosphere. Bone marrow-derived
macrophages (BMM) were isolated according to a slightly
modified standard protocol provided by Invitrogen (Leek,
Netherlands). Briefly, femur and tibia of C57Bl/6 mice were
separated and placed on ice in sterile PBS. The excess
muscle was removed and the ends of the bones were cut
off on both sides. Cells were washed out with a 26-G needle
attached to a sterile syringe, filled with 3 ml DMEM (4,5 g/l
D-glucose, 4 mM glutamine, 110 mg/l sodium pyruvate)
and transferred via a cell strainer into a 50 ml Falcon tube.
Subsequently the cell suspension was centrifuged at 500×g
for 15 minutes and the supernatant was discarded. The cell
pellet was carefully resuspended in DMEM supplemented
with 10% LPDS and 500 U/ml penicillin/streptomycin and
transferred into a culture flask (175 cm2/3 mice) followed
by incubation at 37 °C in a humidified 5% CO2 atmosphere
for 24 h. Nonadherent cells were removed the next day,
counted and resuspended in DMEM containing 10 ng/ml
MCSF (R&D Systems, Minneapolis, USA). Cells were
seeded in 96 well plates (106 cells/100 μl) for the MTT
assay or in 24 well plates (4*106 cells/500 μl) for apoptosis
assays. After 3 and 5 days the medium was replaced with
fresh, supplemented DMEM containing 10 ng/ml MCSF.
Assessment of BMM differentiation
Monocyte differentiation was proven with rat anti-
mouse F4/80-R-PE antibody and rat anti-mouse IgG2a
R-PE isotype control using flow cytometry. The former
monoclonal antibody reacts with the mouse F4/80 anti-
gen, which is a macrophage-specific glycoprotein. Mono-
cyte differentiation was analyzed on the first and seventh
day using RAW264.7 macrophages as a reference. 106
cells were transferred into a FACS tube and centrifuged
at 300×g for 3 minutes. Cells were resuspended in PBS
containing 2 mg/ml glucose. 2,5 μg/ml of the antibody
or the isotype control were added followed by incuba-
tion at room temperature in the dark for 15 minutes.
Stained samples were analyzed using a FACSCalibur in-
strument (BD Biosciences, Heidelberg, Germany). The
red fluorescence emission was measured on channel FL2
above 575 nm upon excitation with a 488 nm laser. Ana-
lysis was performed on the amplitude (heigh, H) of the
fluorescence signal in log scale. The percentage of differ-
entiated cells was calculated using WinMDI 2.8 software.
A content of 90-95% differentiated (F4/80 positive) cells
was considered as appropriate for further experiments.
Incubation of cells with oxPL
Aqueous lipid dispersions containing 0–200 μM oxPL,
POPC or PLPC were prepared using the ethanolinjection method [19]. Cells were incubated with lipid
dispersions in PBS or culture media without phenol red
containing 0-10% (v/v) serum concentrations. The final
ethanol concentration in the incubation mixtures did
not exceed 1% (v/v) of total volume. Culture media or
PBS containing the same ethanol concentration was rou-
tinely used as controls.
MTT viability assay
To determine the cytotoxic effect of oxPL in macro-
phages VybrantW MTT Cell proliferation Assay kit was
used according to the manufacturer’s recommendations.
The MTT assay involves the conversion of the water sol-
uble MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide) to an insoluble formazan by viable
cells. The formazan is solubilized, and its concentration
is determined from the optical density at 570–600 nm.
The protocol was optimized for RAW264.7 and BMM
according to cell number, MTT concentration and incu-
bation times. In brief, 1,25*105 RAW264.7 cells or 106
monocytes were seeded in 96 well plates in culture
medium with varying FCS or LPDS concentrations.
Monocytes were differentiated before incubation as
described above. RAW264.7 cells were left in the wells
for 2–3 h to ensure attachment to the substrate. The
medium was removed and the lipid dispersions or con-
trol substances (1% v/v EtOH, 2,5 mM H2O2, 1 μM
staurosporin) in PBS or culture medium were added.
After incubation, the lipid-containing medium was
replaced by 100 μl fresh medium and 10 μl MTT (1 mg/
ml stock) solution were added prior to incubation at 37°C
in a humidified 5% CO2 atmosphere for 2 h. Subsequently,
100 μl 10% (w/v) SDS in 0,01% (v/v) HCl was added. The
cells were incubated under the same conditions for 4 h.
The mixture was solubilized to homogeneity and optical
density was measured at 595 nm using an Anthos plate
reader driven by WinRead 2.3 software.
Flow cytometric apoptosis assay
Samples were prepared as described for the MTT assay
(see above), except for the cell number and plate format.
Specifically, 6,5 *105 RAW264.7 or 4*106 monocytes
were initially seeded in a 24 well plate (volume 3 ml).
After incubation, cells were harvested by scraping and
washed with cold PBS containing 2 mg/ml glucose prior
to resuspension in Annexin V binding buffer. 3*105
cells/100 μl were transferred into a FACS tube. Five μl
AlexaFluorW488 Annexin V and 5,5 μl propidium iodide
(PI; 1 mg/ml stock solution) were added and allowed to
incubate at room temperature in the dark for 15 minutes.
Prior to FACS measurement, samples were diluted in
400 μl PBS containing 2 mg/ml glucose, gently mixed
and kept on ice until analysis. Stained samples were then
analyzed using a FACSCalibur flow cytometer (BD
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fluorescences were measured at 530 nm and 575 nm, re-
spectively (excitation: 488 nm laser). The [FSC,FL3H]
diagram was applied for gating out the debris and the
gated cells were analyzed in [FL1H, FL2H] log scale dot
plots. Auto-fluorescence of the cells positioned in first
decade, and compensation for AlexaFluorW488 fluores-
cence in FL2 channel was applied. The percentage of
apoptotic cells (AnnexinV-positive), necrotic cells (PI-
positive) and late apoptotic/early necrotic cell (double-
stained) were calculated using WinMDI 2.8 software
package. Apoptotic effects of 1-O-alkylether lipids and
NB19 were compared with PGPC and POVPC-induced
apoptosis under the same conditions except for the cell
number. For these experiments, cells were left overnight
in the multi-well plate and as a consequence, cell num-
bers were twice as high. Cells were pre-incubated with
10 μM NB19 in order to determine the effect of aSMase
on apoptosis. NB19 was dissolved in EtOH before
addition to the culture medium (10 nmol NB19/ml) for
30 minutes. The final ethanol concentrations in the in-
cubation mixtures did not exceed 1% (v/v) of total
volume.
Morphological studies
Monolayer cultures of RAW 264.7(1x105) cells were
seeded in chamber slides (Imaging chamber CG 8 wells,
PAA, Linz, Austria) and grown to 60–80% confluency
over night. Cells were then incubated with 300 μl aque-
ous dispersions of 50 μM oxPLs or reference compounds
(1% v/v EtOH) in DMEM without phenol red under low
serum conditions (0,1% FCS) for 2 h. After incubation
cells were observed with an Axiovert 35 inverted micro-
scope (magnification: 1000 x) equipped with a CCD
camera, driven by AxioVision software package (Carl
Zeiss, Germany).
Proteins of apoptotic blebs
RAW264.7 macrophages were grown to 80% confluency
in Petri-dishes (10 cm diameter) and incubated with an
aqueous dispersion of 50 μM oxPL or 1% (v/v) EtOH in
DMEM under low serum conditions (0,1% FCS) for
18 h. Membrane vesicles and apoptotic blebs were har-
vested as described previously [20]. Briefly, culture
supernatants containing the membrane vesicles were
isolated and cleared from debris and detached cells by
centrifugation at 500×g for 10 minutes. Blebs were iso-
lated by ultracentrifugation (100000×g for 90 minutes at
4°C). The pellet was washed and resuspended in 30 μl
PBS prior to protein determination using a plate assay
according to the method of Bradford [21]. Twenty μl of
pellet suspensions or supernatants (20 μg protein) were
separated by SDS gel electrophoresis (4,5% stacking gel,
10% resolving gel) as previously described [22]. Totalproteins were stained with Sypro Ruby™ and detected using
a BioRad laser scanner (Ex. 488 nm, Em. 530/30 nm).
Time-dependent stability of oxPL
Stability of oxPL in serum-containing media was deter-
mined as previously described [10]. Solvent was removed
from 100 μM oxPL under a stream of nitrogen. Two
hundred μl DMEM containing 10% or 0,1% FCS were
added followed by incubation under shaking (575 rpm)
for 2, 4, 6 or 20 h. After incubation, phospholipids were
extracted with chloroform/methanol 2/1 (v/v) at room
temperature. The organic phase was removed under a
gentle stream of nitrogen. The lipids were then dissolved
in chloroform/methanol 2/1 (v/v) and analyzed by thin-
layer chromatography on silica plates. The mobile phase
was chloroform/methanol/acetone/glacial acetic acid/
water 20/40/10/10/10 (v/v/v/v/v) for PGPC and E-PGPC
and chloroform/methanol/water 50/30/10 (v/v/v) for
POVPC and E-POVPC, respectively. Lipid spots were
detected with molybdenum blue reagent, which specific-
ally stains phospholipids [23].
Acid sphingomyelinase activity
Cultured RAW264.7 macrophages were harvested and
counted using Countess System (Invitrogen). 1,3*106 cells
were plated in 6 well plates followed by incubation at 37°C
in a humidified 5% CO2 atmosphere for 24 h. Subse-
quently, cells were washed with DMEM containing 0,1%
FCS. OxPL containing media was prepared by adding
ethanolic lipid solutions to DMEM at room temperature
under stirring. Cells were incubated with 25 μM oxPL in
DMEM at 37°C in a humidified 5% CO2 atmosphere for
0–15 minutes. Control cells were incubated with 1% etha-
nol (v/v) in DMEM under the same conditions. After in-
cubation, all steps were carried out at 4°C. Cells were
scraped into 1 ml PBS and the cell suspensions were
transferred into 15 ml Falcon tubes followed by centrifu-
gation at 1500 rpm for 10 minutes. The supernatant was
discarded and the cell pellet was resuspended in 50 μl acid
lysis buffer for the determination of aSMase activity as
described previously [24]. Briefly, protein concentration of
the cell lysates was determined using a plate assay accord-
ing to the method of Bradford [21] and aliquots con
taining 20 μg protein were incubated with NBD-
sphingomyelin substrate as described [24]. Substrate and
product were separated by TLC. The fluorescent lipids
were quantified with a CCD camera (Herolab, Vienna)
(excitation wavelength: 365 nm) using EasyWin software.
Statistical analysis
Results are expressed as means +/− standard deviation
(SD). Two-tailed unpaired Student’s t-test was used to
determine the significance of the differences. p-Values ≤
0,05 were considered significant.
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The oxPL PGPC and POVPC are components of oxLDL
which is causally involved in the onset and progression
of atherosclerosis [25]. We have already shown that the
toxicity of oxLDL in cultured vascular smooth muscle
cells is largely due to its oxPL components. PGPC,
POVPC and oxLDL induce apoptosis in these cells,
which is mediated by aSMase generating the second
messenger ceramide [7]. It was the aim of this study to
find out whether and to what extent PGPC and POVPC
(Figure 1) induce (programmed) cell death in macro-
phages, which is a hallmark in atherogenesis.
For this purpose, we used the established RAW264.7
macrophage-like cell line and cultured murine BMM. In a
pre-screen, the effects of both oxPL on cell viability were
studied using the photometric MTT assay (Figure 2). From
the decrease in optical density of the marker dye it can be
concluded that both compounds decreased the viability of
RAW264.7 cells in a concentration- and for PGPC in a time-
dependent manner (Figure 2A and B) with PGPC being
more toxic than POVPC. Notably, BMM were more sensitive
towards the oxPL than RAW264.7 cells (Figure 2C and D).
Lysophosphatidylcholine (PLPC) showed comparable
effects on viability as PGPC (Figure 2). PLPC and the
oxPL show similar structural features since they contain
only one long-chain fatty acyl residue in position sn-1
and a polar group in position sn-2 of glycerol. Since
PLPC is formed upon hydrolytic degradation of PGPC
and POVPC (see also Figure 3), it can be expected that
it contributes to the toxicities of these lipids to some ex-
tent, especially after long incubation times.
Cell damage detected by the MTT assay is in line with
the morphological changes that are observed under the
microscope (Figure 4). Upon treatment with oxPL
RAW264.7 cells show morphological changes such as
rounding and shrinking and are eventually released from
the solid substratum.Figure 1 Chemical structures of oxidized phospholipids. PGPC: 1-palm
hexadecyl-2-glutaroyl-sn-glycero-3-phosphocholine. POVPC: 1-palmitoyl-2-(5
hexadecyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine.The detrimental effects of both oxPL on cell viability are
associated with an increase in apoptosis. Programmed cell
death under the influence of PGPC and POVPC was
determined from cell staining with fluorescent Annexin V
followed by FACS analysis. In addition, the capacity of the
oxPL to induce necrosis was measured in the same experi-
ment using PI as dye that stains the DNA in cells with
permeabilized membranes. Staurosporine and hydrogen
peroxide were used as control toxins to assess apoptosis
and necrosis, respectively. PGPC and POVPC induced
apoptosis in both cell types with PGPC being again more
toxic than POVPC (Figure 5A and B). Cells incubated
with either oxPL hardly showed any signs of necrosis (data
not shown). As observed before, BMM were more sensi-
tive to the oxPL than RAW264.7 macrophages. We also
studied apoptosis of both cell types under the influence
of the 1-O-alkyl-2-acyl analogs of PGPC and POVPC
(Figure 1). The respective compounds are oxidation pro-
ducts of ether choline phospholipids that are also found in
LDL and cell membranes of animals and humans [26].
The ether analogs of PGPC and POVPC and their diacyl
counterparts showed very similar apoptotic effects in
RAW264.7 cells, with the PGPC analog being more toxic
than the POVPC analog (Figure 5C). It is obvious that the
toxicities of the diacyl and alkylacyl oxPL depend on the
small structural difference in the oxidized sn-2 acyl chain.
The (ether) POVPC contains an aldehyde group which
can react with the amino groups of phospholipids and pro-
teins, whereas PGPC can only undergo physical interac-
tions with the molecules in its close vicinity. As a
consequence, cellular lipid uptake, membrane effects, sig-
naling platforms and the outcome, cell death, are different.
Toxicity of oxPL in macrophages depends on lipid sta-
bility inside the cells and in the culture medium prior to
cellular uptake. The cell viability and apoptosis experi-
ments were performed under low (0,1%) serum condi-
tions. In order to determine the stability of the oxPL,itoyl-2-glutaroyl-sn-glycero-3-phosphocholine. Ether-PGPC: 1-O-
-oxovaleroyl)-sn-glycero-3-phosphocholine. Ether-POVPC: 1-O-
Figure 2 Effects of oxPL on viability of RAW264.7 cells and BMM. RAW264.7 cells (Panel A and B) and BMM (Panel C and D) were incubated
with lipid dispersions in DMEM under low serum conditions (0,1% FCS) using various lipid concentration and incubation times. Cell viabilities
were determined using the MTT assay described under materials and methods. Indicated values are relative viabilities (viabilities of control cells
were set 1). Results obtained with RAW264.7 cells are means of 6 replicates out of three independent experiments. Results obtained with BMM
(isolated and pooled from femurs and tibias of 3 or 5 mice, see materials and methods) are means of 4 replicates out of two independent
experiments. Significance was determined by Student’s t-test (two tailed, unpaired). * p≤ 0,05, *** p≤ 0,005.
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in the culture medium, followed by solvent extraction and
TLC analysis. Under low serum conditions (0,1% FCS),
POVPC (Figure 3A) and ether-POVPC (Figure 3B) were
stable for 2 h, whereas PGPC (Figure 3A) and ether-PGPC
(Figure 3B) remained intact for 6 h. This difference can
help explain at least in part the higher toxicities of the
PGPC versus the POVPC-derived lipids. Addition of 10%
serum to the culture medium efficiently catalyzed the hy-
drolysis of PGPC, POVPC (Figure 3A) and their ether
analogs (Figure 3B) to the formation of PLPC. After 2 h of
incubation, the entire amount of lipid has gone under
these high serum conditions.
Apoptosis is associated with a series of profound
changes in cellular structure and integrity. Membrane
blebbing, the release of vesicular bodies (blebs) from the
plasma membrane, is one of the hallmarks of thisprocess [27-29]. To measure the capacity of the oxPL to
induce membrane blebbing in RAW264.7 macrophages,
cells were incubated with 50 μM PGPC or POVPC for
18 h (Figure 6). The vesicle pellets (P) were isolated
from the supernatant (SN) by ultracentrifugation and
analyzed for their protein patterns and contents. The
protein patterns of the apoptotic vesicles (P) slightly
depended on the oxPL. However, the efficiency as deter-
mined from the protein amount in the membrane frac-
tion (P) differed to a great extent depending on the lipid.
Concerning the protein content we found that PGPC led
to a much more pronounced release of apoptotic vesi-
cles than POVPC.
In a previous study, we found that POVPC and (to a
lesser extent) PGPC-induced apoptosis was mediated by
the fast activation of an aSMase in cultured vascular
smooth muscle cells [7]. This enzyme generates ceramide
Figure 3 Time-dependent stability of oxPL in culture media under different serum conditions. OxPL were incubated in DMEM containing
0,1% or 10% serum for different time periods. Subsequently, lipids were isolated by solvent extraction and separated by TLC. Mobile phase for
PGPC (Rf = 0,43) and E-PGPC (Rf = 0,36), POPC (Rf >0,30) and PLPC (Rf = 0,18) was chloroform/methanol/acetone/glacial acetic acid/water 20/40/
10/10/10 (v/v/v/v/v). For POVPC (Rf = 0,35) and E-POVPC (Rf = 0,32), POPC (Rf >0,25) and PLPC (Rf = 0,15) the mobile phase was chloroform/
methanol/water 50/30/10 (v/v/v) Under high serum conditions (10% FCS), POVPC and PGPC were converted to lysophospholipids. Under low
serum conditions (0,1% FCS), PGPC was stable for at least 6 h, whereas POVPC started getting degraded immediately (Panel A). Notably, the
major amount of oxPL stayed intact during the incubation times used for cell experiments. The 1-O-alkyl ether analogs showed the same
stabilities as their acyl counterparts (Panel B).
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nal. The data presented in this work provide evidence that
both oxPL induce apoptosis also in cultured macrophages,
but the role of aSMase seems to be different in the latter
cells. POVPC and ether-POVPC activate aSMase within
minutes (Figure 7A). The ether-POVPC stimulates the en-
zyme more efficiently. This result is in line with the
slightly higher, toxicity of the ether-POVPC. FACS analysis
of apoptosis in RAW264.7 macrophages provided evi-
dence that aSMase activity is directly linked to the toxicity
of POVPC. Pre-incubation of the cells with an enzyme in-
hibitor (NB19) reduced the amount of apoptotic cells after
exposure to the oxPL (Figure 7B). NB 19 did not influence
the basal level of apoptosis in control cells without (ether-)
POVPC. PGPC and ether-PGPC show an opposite effect
as they inhibit aSMase in macrophages (Figure 7A).
We have evidence that PGPC utilizes enzymes of the de
novo pathway for ceramide production and signaling(unpublished). Interestingly, inhibition of aSMase expres-
sion by NB19 protects cells against the toxicity of PGPC
(Figure 7B), although there is no direct effect of the oxPL
on enzyme activity. According to these data, there must be
at least one indirect relationship between aSMase and
PGPC-induced cell death. This open question will be sub-
ject to further clarification.
Discussion
Apoptosis of macrophages in the arterial wall is a hall-
mark in the development of atherosclerosis [29]. Accu-
mulation of apoptotic cells along with a transition to cell
necrosis contribute to the destabilization of atheroscler-
otic plaques followed by plaque rupture and thrombus
formation [30]. The endpoint of the development of
this chronic disease may be myocardial infarction or
stroke. From in vitro experiments it is known that
the interaction of oxidized lipoproteins with cultured
Figure 4 Morphological changes in RAW264.7 macrophages. Photomicrographs (magnification: 1000x) of RAW264.7 cells after incubation
with POVPC and PGPC in DMEM containing 0,1% FCS for 2 h. Control cells were incubated with 1% v/v EtOH. Signs of cellular damage are cell
detachment, morphological changes and membrane vesicle formation.
Figure 5 Apoptotic effects of oxPL in RAW264.7 cells and BMM. Cells were incubated with the indicated concentrations of oxPLs in media
under low serum conditions (0,1% FCS) for 4 h and analyzed by flow cytometry (see materials and methods). The fraction of apoptotic cells was
determined from Annexin V staining of externalized phosphatidylserine. Control cells were incubated with 1% v/v Ethanol (EtOH). 2,5 mM H2O2
or 1 μM staurosporin (STS) in the incubation media, which were used as reference agents inducing necrosis or apoptosis, respectively. Panel A:
50 μM POVPC and PGPC induce apoptosis in RAW264.7 macrophages. PGPC is a more potent inducer of cell death than POVPC under these
conditions. Results are means of 6 replicates out of three independent experiments. Panel B: 50 μM PGPC and POVPC induce apoptosis in BMM,
which are slightly more sensitive to the oxPL compared with RAW264.7 macrophages. Results are means from one representative experiment of
4 replicates of one pooled sample (BMM isolated and pooled from femurs and tibias of 5 mice, see materials and methods). Panel C: 50 μM 1-O-
alkyl ether analogs of PGPC and POVPC (E-PGPC and E-POVPC, respectively) induce apoptosis in RAW264.7 macrophages. Panel D: Representative
histogram of RAW264.7 cells after exposure to 1% v/v Ethanol (EtOH), 1 μM staurosporin (STS), POVPC or PGPC. Experimental conditions as
described under Panel A. All Results are expressed as means +/− SD. Significance was determined by Student’s t-test (two tailed, unpaired).
** p≤ 0,01, *** p≤ 0,005.
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Figure 6 Protein pattern of apoptotic blebs. RAW264.7 cells were incubated with 50 μM PGPC or POVPC or 1% (v/v) EtOH under low serum
conditions (0,1% FCS) for 18 h. Membrane vesicles were isolated by ultracentrifugation and resuspended in PBS. Proteins of pellets (P) and
supernatants (SN) obtained after ultracentrifugation were separated by SDS-PAGE as described in materials in methods section. Vesicles produced
by POVPC and PGPC show slightly different protein patterns. More vesicles protein is released under the influence of PGPC.
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fate under pathophysiological conditions [25]. oxLDL,
characterized by a high content of modified lipid and
protein components, is incorporated into the cells via scav-
enger receptors without regulatory feedback mechanisms.
As a consequence, lipids accumulate inside the cells and
foam cells are formed. In mmLDL, a significant fraction
of cholesterol and (phospho) lipid esters containing
polyunsaturated fatty acids are modified or fragmented,
whereas apolipoprotein B (apoB) is hardly affected [29].
These particles are also very toxic to macrophages and
other cells of the vascular wall, depending on the extent
of lipoprotein modification, dose and incubation time.
mmLDL is still recognized by the apoB receptor, but its
toxicity does not depend on receptor-mediated uptake
of the entire particle [31]. OxPL and especially those
containing fragmented acyl chains are more polar and
can be efficiently transferred to cell plasma membranes
through the aqueous phase [14,15]. Sustained exposure
to mmLDL induces apoptosis in cultured vascular cells
and macrophages [3,4,7], which is mediated by the acti-
vation of an aSMase generating the apoptotic lipid mes-
senger ceramide. We have already shown that the
truncated phospholipids PGPC and POVPC mimic the
toxic effects of mmLDL in cultured vascular smoothmuscle cells [7]. Here we provide evidence that both
oxPL induce apoptosis in cultured macrophages. In these
studies, we investigated RAW264.7 macrophage-like cells
and BMM. The tendencies of PGPC and POVPC to in-
duce apoptosis were the same in both cell types with
BMM being slightly more susceptible to oxPL toxicity
than RAW264.7 macrophages. Despite the fact that pri-
mary bone marrow-derived cells were included in our
study it has to be noted that the results obtained in vitro
cannot be directly translated in vivo, in particular not
to human conditions.
The mechanisms of oxPL toxicity in RAW264.7 cells
were studied in more detail and seem to differ from the
pathways observed in cultured smooth muscle cells.
POVPC rapidly activated aSMase in cultured RAW264.7
macrophages. When aSMase activity was inhibited by
NB19, cells became more resistant to POVPC-induced
apoptosis, indicating that the activity of this enzyme is
causally linked to POVPC toxicity in macrophages. Simi-
larly, apoptosis induced by Jurkat cell-derived micropar-
ticles in RAW 264.7 macrophages was reduced when the
cells were treated with an aSMase inhibitor [32]. How-
ever, it has to be emphasized that the (oxidized) lipid
composition of microparticles is complex and therefore
it is not possible to attribute toxic effects to discrete
Figure 7 Effects of oxPL on aSMase activity and aSMase-mediated apoptosis. Panel A: RAW264.7 cells were incubated with DMEM
containing 25 μM of lipid or 1% v/v EtOH (control) for 5 or 15 minutes. Cells were harvested and lysed and sphingomyelinase activity was
determined as described under materials and methods. Results are shown as relative values (folds of controls). The absolute enzyme activities of
the control cells in the individual experimental series ranged from 4 to 8 pmol/min/μg protein. POVPC and E-POVPC increase aSMase activity
within 5 minutes. PGPC and E-PGPE had a slightly inhibitory effect on enzyme activity as compared to the control. Panel B: RAW264.7 cells were
incubated with 50 μM oxPLs in media under low serum conditions (0,1% FCS) for 4 h and analyzed by flow cytometry. The fraction of apoptotic
cells was determined from Annexin V staining of externalized phosphatidylserine. Control cells were incubated with 1% v/v EtOH with or without
NB19 in the incubation media. Inhibition of aSMase with NB19 (10 nmol/ml) leads to significant decrease in apoptosis induced by POVPC and
PGPC. NB19 alone had no significant effect on cell viability. Results are means of 4 replicates out of 3 experiments. Data are expressed as means
+/− SD relative to the control. Significance was determined by Student’s t-test (two tailed, unpaired). * p≤ 0,05, **p≤ 0,01.
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effect on aSMase after 15 minutes incubation. Data from
preliminary experiments support the assumption that
PGPC interferes with the enzymes of de novo ceramide
synthesis localizing to intracellular membranes (ER),
whereas aSMase likely generates ceramide in the plasma
membrane (Koller D., Marlingapla Halasiddappa L.,
Hermetter A., unpublished). The obviously different roles
of ceramide-generating pathways in PGPC- and POVPC-
induced macrophage apoptosis are due to the small
structural differences in the short-chain carboxylic acids
that are the remnants of arachidonic acid oxidation in
position sn-2 of the parent glycerophospholipids. PGPC
contains a carboxylic function at the ω-position of thetruncated acyl chain, whereas POVPC contains a chem-
ically reactive aldehyde group. PGPC can only physically
interact with the biomolecules in its immediate vicinity.
It is rapidly internalized by the cells [33] and thus can
influence the metabolic activities (ceramide synthesis)
inside the cells. In contrast, POVPC is retained in the
plasma membrane due to covalent Schiff base formation
with the free amino groups of proteins and aminopho-
spholipids [14,15]. This behaviour is in line with the obser-
vation that POVPC rapidly activates aSMase, which
localizes at least in part to the cell surface. After long
exposure time, POVPC can also reach the intracellular
compartments where it modifies numerous cytosolic
and membrane proteins [14]. In this regard, it behaves
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ment released from the ω-end of polyunsaturated fatty
acids under oxidative stress [34]. Notably, HNE is more
polar than POVPC and therefore partitions more easily
into the cytosol and eventually the intracellular mem-
branes where it covalently modifies proteins thereby trig-
gering apoptosis, necrosis and inflammation [35,36] HNE
is currently considered the major biomarker of lipid per-
oxidation [37].
In addition to diacylglycerophospholipids (mainly phos-
phatidylcholine), LDL also contains small amounts of alk
(en)yl-acyl-analogs. Animal and human cell membranes,
except the liver, may even contain large amounts of this
phospholipid subclass [26,38-40]. Most alk(en)ylacyl phospho-
lipid species (mainly containing phosphocholine- and etha-
nolamine head groups) also contain polyunsaturated fatty
acyl chains in position sn-2 of glycerol and therefore are
subject to modification by reactive oxygen species [11].
Here we show that the alkylacyl analogs of PGPC and
POVPC are also potent inducers of apoptosis in RAW264.7
macrophages. The same effects were also observed in cul-
tured vascular smooth muscle cells (unpublished). Cur-
rently, we do not know the reason for the higher ether lipid
toxicities, which may be due to differences in biochemical
stability and biophysical properties in the cell [41]. The
sn-1 alkylether bond is resistant to hydrolytic cleavage
and thus increases biochemical stability of the lipid mol-
ecule. From biophysical studies it is known that alkylacyl
phospholipids are more densely packed [42] and increase
the tendency of the membrane or some membrane areas
to adopt nonbilayer lipid phases leading to membrane
destabilization and alterations of membrane-associated
enzyme functions.
One of the most striking phenomena of apoptosis is the
controlled disintegration of cell (membrane) structures as
a consequence of membrane blebbing, which is the release
of microparticles (apoptotic blebs) into the immediate
environments or the circulation. These particles are
enriched in oxPL (mainly PGPC, POVPC and PEIPC)
[20,43] and thus must be considered vehicles of toxic
compounds that trigger detrimental effects far from the
site of their formation. As a consequence they can propa-
gate apoptotic and inflammatory processes within the
same tissues or other organs [44,45]. The formation of
microparticles may be favoured by the physical properties
of the truncated phospholipids themselves [33] and/or the
ceramide that is formed during the progress of apoptosis
[46]. We found that PGPC leads to massive microparticle
formation, whereas POVPC induced less vesicle release.
The molecular shape of PGPC is conical and therefore
it can directly induce high membrane curvature, a pre-
requisite for membrane vesiculation. The role of ceramide
in PGPC-induced membrane blebbing is not obvious.
PGPC seems to affect intracellular ceramide formationand to date it is unclear how the sphingolipid can reach
the plasma membrane and contribute to cell surface-
associated membrane effects under oxPL stress. A role of
ceramide in POVPC-induced membrane blebbing is more
plausible. The latter phospholipid stimulates aSMase and
as a consequence ceramide can directly be generated in
the plasma membrane. A direct contribution of POVPC
to microparticle formation cannot be inferred from the
currently available information. The preparation of typical
lipid-lipid and lipid-protein conjugates of POVPC, which
forms Schiff bases with free amino groups of proteins and
aminophospholipids, is under way in our laboratory in
order to characterize the biophysical properties and cellu-
lar effects of these membrane-associated components.
Conclusions
In summary, PGPC, POVPC and their 1-O-alkyl analogs
induce apoptosis in cultured macrophages with PGPC
and ether-PGPC being more toxic than the POVPC
counterparts. The higher toxicities are associated with
more severe consequences to the cells. Loss of plasma
membrane vesicles is more efficient if cells are exposed
to PGPC. This result is physiologically highly relevant
since apoptotic blebs contain large amounts of oxPL and
carry these toxic compounds far away from the site of
formation [20]. Thus the biological activity of oxPL is
potentiated by this process. We conclude that the apop-
totic effects of POVPC and its ether analog are coupled
to the activity of aSMase. It remains to be elucidated,
which pathway accounts for the formation of toxic cera-
mide under the influence of PGPC.
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